Maryles Joel Michael's Form 4 filing
Chemomab Therapeutics Ltd. (CMMB) · filed May 25, 2022
- Accession no.
- 0001178913-22-002173
- Filed
- May 25, 2022
- Trade date
- Apr 19, 2021-May 24, 2022
- Filing delay
- 401 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $1.25K. It was filed 401 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maryles Joel MichaelCIK 0001850990 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2022 | American Depositary Shares | PPurchaseAcquired | +400 | $2.89 | +$1,156 | 1,400 | Direct | |
| May 24, 2022 | American Depositary Shares | PPurchaseAcquired | +33 | $2.76 | +$91.08 | 1,433 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | American Depositary Shares | AGrant or awardAcquired | +6,820 | $0.00 | $0 | 6,820 | Direct | Duplicate filing |
| Apr 19, 2021 | American Depositary Shares | AGrant or awardAcquired | +11,884 | $0.00 | $0 | 11,884 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.